DexCom, Inc. (DXCM) Reports Q3 Loss of 20c, Misses by 4c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $88.96 -0.22%
Financial Fact:
Interest expense: -200K
Today's EPS Names:
EGRX, VAXX, AFIB, More
Financial Fact:
Interest expense: -200K
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
DexCom, Inc. (NASDAQ: DXCM) reported Q3 EPS of ($0.20), $0.04 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $18.3 million versus the consensus estimate of $19.05 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
- Agilent Technologies (A) Tops Q3 EPS by 13c, Beats on Revenue; Offers FY EPS Guidance
- Lantronix (LTRX) Reports In-Line Q4 EPS; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
